The global cancer immunotherapy market was valued at $45,471 million in 2015, and is projected to reach $117,114 million by 2022, growing at a CAGR of 14.5% from 2016 to 2022. The monoclonal antibodies segment held two-third share of the total market in 2015. Cancer immunotherapy, also known as biologic therapy, helps in cancer treatment by boosting the immunity of the body to fight against cancer. In this type of therapy antibodies and live viruses are introduced in the body that slows the growth of cancer cells. In addition, it also helps the immune system destroy the cancer cells. The major factors that drive the growth of this market include increase in incidence of cancers, growth in geriatric population, and rise in cancer R&D. However, shortage of skilled labor and lack of awareness about cancer immunotherapy is projected to restrain the market growth during the forecast period. Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2244 The cance
A sector as vibrant as Life Sciences requires a dedicated team to keep pace with continuous changes in dynamics. At Allied Market Research, we offer experts’ opinion and proficiency to move into new zones of the business. Here, the life sciences sector covers diverse portfolios, such as restorative gadgets, and more extensive issues such as pharmaceutical outsourcing and method, and specialty parts, including drug convenience. In addition, it comprehends key patterns and developments in this sec